CTI BioPharma Corp.

CTICNASDAQHealthcare

$9.10

+$0.01(+0.06%)

Market Cap$1.2B

P/E Ratio—

52W High$9.1

52W Low$4.01

Avg Volume6.4M

Open$9.10

Beta0.83

Forecast Market Cap PE Ratio

CTI BioPharma Corp.（CTIC）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ctic · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2024年3月26日

分析师评级与共识

基于过去 3 个月内 19 位华尔街分析师

Buy

19 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 19 · 买入占比: 68.4%

12 个月目标价

High

$13.00

Consensus

$10.40

+14.4% upside

Low

$9.00

Median: $9 · Last Close: $9.09

CTI BioPharma Corp.（CTIC）的分析师共识为 Buy，基于过去 3 个月内 19 位华尔街分析师的评级。CTIC 的 12 个月平均目标价为 $10.40，相对当前价 $9.09 代表 +14.4% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $10 (14.4%)High $13Low $9

Consensus Target

$10.40

14.4% upside

High Target

$13

43.0%

Low Target

-1.0%

Current Price

$9.09

as of today

Based on analyst price targets, the CTIC stock price prediction for the next 12 months ranges from $9 to $13. The consensus CTIC price forecast of $10.40 implies 14.4% upside from the current price of $9.09.

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$9.09	↓ 0.03%	$9.08	$9.09

1-day model range: $9.08–$9.09. Peak: $9.09 (-0.03%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%57%0%

6Buy

8Neutral

0Sell

RSI (14)70.0Neutral

MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · CTIC · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$9.09BUY

MA 10$9.08BUY

MA 20$9.06BUY

MA 50$0.00NEUTRAL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $CTIC · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$9.09BUY

EMA 10$9.08BUY

EMA 20$9.05BUY

EMA 50$0.00NEUTRAL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $CTIC · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2023-05-24	JMP Securities	Maintains	Market Perform→Perform
2023-05-16	SVB Leerink	Downgrade ↓	Outperform→Perform
2023-05-15	Stifel	Downgrade ↓	Buy→Hold
2023-05-11	Needham	Downgrade ↓	Buy→Hold
2023-05-11	JMP Securities	Downgrade ↓	Market Outperform→Perform
2023-04-19	Needham	Maintains	Buy→Buy
2023-04-17	TD Cowen	Maintains	Outperform→Outperform
2023-03-07	JMP Securities	Maintains	Market Outperform→Outperform
2023-03-06	Needham	Maintains	Buy→Buy
2023-02-06	JMP Securities	Maintains	Market Outperform→Outperform

JMP Securities2023-05-24

Maintains

Market Perform→Perform

SVB Leerink2023-05-16

Downgrade ↓

Outperform→Perform

Stifel2023-05-15

Downgrade ↓

Buy→Hold

Needham2023-05-11

Downgrade ↓

Buy→Hold

JMP Securities2023-05-11

Downgrade ↓

Market Outperform→Perform

Needham2023-04-19

Maintains

Buy→Buy

TD Cowen2023-04-17

Maintains

Outperform→Outperform

JMP Securities2023-03-07

Maintains

Market Outperform→Outperform

Needham2023-03-06

Maintains

Buy→Buy

JMP Securities2023-02-06

Maintains

Market Outperform→Outperform

Wall Street analysts have recently issued updated ratings on CTI BioPharma Corp. (CTIC) stock. Of the recent 40 rating actions, 1 were upgrades and 8 were downgrades. 19 analysts currently cover CTIC.

分析师推荐趋势

Buy ratings1 → 0↓ 1

Hold ratings0 → 5↑ +5

Sell ratings0 → 0

CTIC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

—

Revenue Next Year

—

EPS This Year

—

EPS Next Year

—

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CTIC EPS of $— for the current fiscal year, based on estimates from 0 analysts. The CTIC revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CTIC 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CTIC 的共识目标价为 $10.40（+14.4% 上行空间），分析师共识为 Buy。

CTIC 的短期预测（明日）为 $9.09（-0.03%）。

CTI BioPharma Corp. 在 NASDAQ 上市，代码 CTIC。CTIC 在 2027 年的整体展望偏积极，在覆盖分析师中约 68% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CTIC 预测 · 8 个问题

根据 19 位华尔街分析师，CTIC 的 12 个月平均目标价为 $10.40，最高 $13.00、最低 $9.00。若有图表，中位目标价可在上方查看。相对当前价 $9.09，隐含约 +14.4% 的上行空间。

CTIC 目标价CTIC 分析师目标价CTIC 12个月目标价目标价 CTIC

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.